118 related articles for article (PubMed ID: 9408461)
1. The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy.
White HS; Wolf HH; Woodhead JH; Kupferberg HJ
Adv Neurol; 1998; 76():29-39. PubMed ID: 9408461
[TBL] [Abstract][Full Text] [Related]
2. The Antiepileptic Drug Development Program: an example of government-industry collaboration.
White BG
Prog Clin Biol Res; 1985; 197():83-93. PubMed ID: 4070302
[TBL] [Abstract][Full Text] [Related]
3. Advances in the clinical development of antiepileptic drugs.
Porter RJ; Hessie BJ; Cereghino JJ; Gladding GD; Kupferberg HJ; Scoville B; White BG
Fed Proc; 1985 Jul; 44(10):2645-9. PubMed ID: 3891417
[TBL] [Abstract][Full Text] [Related]
4. Carisbamate, a new carbamate for the treatment of epilepsy.
Kulig K; Malawska B
IDrugs; 2007 Oct; 10(10):720-7. PubMed ID: 17899491
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
Klitgaard H
Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant mechanisms for today and tomorrow.
Southam E; Stratton SC; Davies CH
Drug News Perspect; 2005 Oct; 18(8):483-7. PubMed ID: 16391717
[TBL] [Abstract][Full Text] [Related]
8. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
[TBL] [Abstract][Full Text] [Related]
9. New drugs for persons with epilepsy.
Blum DE
Adv Neurol; 1998; 76():57-87. PubMed ID: 9408464
[TBL] [Abstract][Full Text] [Related]
10. Animal models used in the screening of antiepileptic drugs.
Kupferberg H
Epilepsia; 2001; 42 Suppl 4():7-12. PubMed ID: 11564118
[TBL] [Abstract][Full Text] [Related]
11. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Privitera M
Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139
[TBL] [Abstract][Full Text] [Related]
12. [Specific antiepileptic therapy in childhood].
Kelemen A; Bozić K; Zikić M; Gebauer K; Filipović D
Med Pregl; 1999; 52(9-10):343-50. PubMed ID: 10624382
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical industry screening for new antiepileptic drugs.
Taylor CP; Marks JL
Adv Neurol; 1998; 76():41-7. PubMed ID: 9408462
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam: a new therapeutic option for refractory epilepsy.
Pinto A; Sander JW
Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
[TBL] [Abstract][Full Text] [Related]
15. The Anticonvulsant Screening Program of the National Institute of Neurological Disorders and Stroke, NIH: History and Contributions to Clinical Care in the Twentieth Century and Beyond.
Porter RJ; Kupferberg HJ
Neurochem Res; 2017 Jul; 42(7):1889-1893. PubMed ID: 28275952
[TBL] [Abstract][Full Text] [Related]
16. Practical prescribing and long-term efficacy and safety of zonisamide.
Leppik IE
Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic drug treatment in children.
Hadjiloizou SM; Bourgeois BF
Expert Rev Neurother; 2007 Feb; 7(2):179-93. PubMed ID: 17286551
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
20. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs.
Reife RA
Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
